Name | Home Sweet Home Care |
---|---|
Location | 16 West Sixth Street, Atlantic, Iowa |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
Medicare ID | 167239 |
Ownership Type | Proprietary |
Service Area Zip Codes | 50002, 50020, 50022, 50601, 50833, 50843, 50851, 50864, 51535, 51551, 51566, 51601, 51632, 51638, 51640, 51646 |
NPI Number | 1932252020 |
Organization Name | HOME SWEET HOME CARE INC. |
Address | 16 W 6th St, Atlantic, IA 50022 |
Phone Number | 712-542-4181 |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
Quality Rating: |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 97.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 98.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 72.2 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 80.2 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.9 | 96.4 |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 65.3 | 79.6 |
How often patients got better at getting in and out of bed | 73.3 | 81.1 |
How often patients got better at bathing | 86.2 | 82.3 |
How often patients’ breathing improved | - | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 50.8 | 75 |
How often home health patients had to be admitted to the hospital | 10 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 5.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 88.1 | 94 |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
The patient survey data of Home Sweet Home Care is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 89 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 77 | 78 |
News Archive
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.
The Center for Technology and Aging today released grant application guidelines for a $500,000 Medication Optimization Diffusion Grants Program. Up to six one-year grants will be made to organizations successfully proposing programs that directly benefit older adults. Four or five grants will focus on Californians, while one or two may benefit older adults in other regions of the U.S.
Lumenis Ltd., the world's largest medical laser company and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for Aesthetic, Surgical and Ophthalmic applications, and Alma Lasers, Ltd., a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications, announce that they have settled all patent claims and counterclaims in a litigation between Lumenis and its subsidiary, Lumenis Inc. and Alma and its subsidiary, Alma Lasers Inc..
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
› Verified 9 days ago
Home Sweet Home Care Location: 16 West Sixth Street, Atlantic, Iowa 50022 Ratings: Phone: (712) 243-5343 |